[ 1] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 2] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 3] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 4] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 5] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 6] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 7] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 8] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 9] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 10] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 11] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 12] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 13] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 14] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 15] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 16] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 17] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 18] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 19] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 20] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 21] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 22] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 23] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 24] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 25] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 26] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 27] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 28] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 29] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 30] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 31] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 32] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 33] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 34] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 35] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 36] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 37] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 38] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 39] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 40] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 41] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 42] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 43] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 44] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 45] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 47] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 48] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 49] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 50] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 51] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 52] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 53] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 55] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 56] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 57] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 58] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 59] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 60] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 61] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 62] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 63] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 64] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 65] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 66] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 67] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 68] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 69] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 70] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 71] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 72] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 73] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 74] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 75] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 76] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 77] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 78] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 79] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 80] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 81] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 82] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 83] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 84] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 85] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 86] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 87] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 88] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 90] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 91] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 92] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 93] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 94] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 95] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 96] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 97] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 98] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 99] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [100] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [101] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [102] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [103] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [104] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [108] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [109] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [110] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [111] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [112] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [113] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [114] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [115] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [116] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [118] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [119] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [120] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [123] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [124] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [125] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [126] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [127] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [128] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [129] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [131] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [132] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [133] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [134] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [137] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [140] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [141] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [142] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [143] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [144] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [147] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [148] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [149] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [150] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [151] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [152] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [154] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [155] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [157] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [158] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [159] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [160] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [161] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [162] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [164] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [165] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [166] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [167] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [168] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [169] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [170] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [171] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [172] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [173] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [176] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [177] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [178] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [179] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [180] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [181] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [182] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [183] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [184] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [185] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [186] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [187] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [188] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [189] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [190] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [193] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [195] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [196] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [197] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [198] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [199] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [200] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [201] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [202] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [203] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [204] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [205] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [206] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [208] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [209] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [210] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [211] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [212] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [213] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [214] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [216] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [217] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [218] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [219] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [220] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [221] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [222] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [223] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [224] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [225] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [226] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [228] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [229] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [230] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [231] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [232] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [236] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [237] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [238] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [239] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [240] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [241] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [242] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [243] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [244] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [245] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [246] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [247] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [248] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [249] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [250] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [251] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [252] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [253] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [259] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [260] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [261] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [262] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [263] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [264] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [265] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [266] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [267] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [268] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [270] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [272] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [273] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [274] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [275] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [278] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [280] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [281] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [282] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [283] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [284] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [285] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [286] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [288] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [289] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [290] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [292] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [293] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [295] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [296] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [297] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [298] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [300] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [303] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [304] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [305] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [306] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [307] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [308] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [309] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [310] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [312] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [313] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [314] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [315] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [316] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [317] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [318] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [319] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [320] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [321] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [322] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [323] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [324] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [325] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [326] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [327] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [328] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [329] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [330] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [331] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [332] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [333] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [334] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [335] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [336] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [337] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [338] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [339] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [340] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [342] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [343] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [344] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [345] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [346] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [347] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [348] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [349] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [350] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [351] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [352] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [353] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [354] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [355] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [356] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [357] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [358] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [359] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [360] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [361] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [363] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [364] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [365] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [366] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [367] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [368] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [369] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [370] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [371] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [372] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [373] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [374] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [375] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [376] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [377] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [380] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [381] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [382] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [383] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [384] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [385] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [386] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [387] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [388] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [389] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [390] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [391] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [392] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [393] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [394] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [395] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [396] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [397] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [398] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [399] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [400] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [401] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [402] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [404] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [405] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [406] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [409] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [410] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [411] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [412] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [413] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [414] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [415] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [416] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [417] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [418] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [419] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [421] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [422] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [423] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [424] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [425] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [426] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [427] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [428] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [429] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [430] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [432] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [435] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [436] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [438] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [439] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [440] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [441] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [442] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [443] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [444] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [445] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [446] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [447] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [448] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [449] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [450] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [451] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [452] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [453] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [454] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [455] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [456] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [457] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [458] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [459] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [461] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [467] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [468] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [469] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [470] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [471] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [472] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [473] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [474] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [475] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [476] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [477] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [478] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [479] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [480] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [481] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [482] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [483] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [484] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [485] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [486] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [487] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [488] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [489] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [490] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [491] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [492] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [493] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [494] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [495] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [496] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [497] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [498] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [499] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [500] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [501] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [502] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [503] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [504] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [505] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [506] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [507] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [508] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [509] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [510] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [511] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [512] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [513] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [514] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [515] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [516] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [517] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [518] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [519] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [520] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [521] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [522] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [523] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [524] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [525] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [526] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [527] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [528] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [529] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [530] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [531] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [532] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [533] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [534] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [535] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [536] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [537] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [538] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [539] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [540] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [541] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [542] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [543] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [544] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [545] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [546] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [547] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [548] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [549] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [550] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [551] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [552] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [553] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [554] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [555] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [556] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [557] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [558] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [559] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [560] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [561] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [562] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [563] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [564] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [565] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [566] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [567] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [568] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [569] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [570] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [571] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [572] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [573] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [574] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [575] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [576] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [577] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [578] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [579] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [580] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [581] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [582] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [583] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [584] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [585] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [586] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [587] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [588] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [589] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [590] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [591] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [592] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [593] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [594] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [595] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [596] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [597] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [598] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [599] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [600] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [602] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [603] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [604] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [605] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [606] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [607] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [608] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [609] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [610] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [611] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [612] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [613] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [614] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [615] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [616] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [617] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [618] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [619] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [620] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [621] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [622] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [623] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [624] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [625] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [626] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [627] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [628] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [629] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [630] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [631] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [632] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [633] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [634] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [635] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [636] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [637] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [638] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [639] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [640] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [641] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [642] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [643] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [644] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [645] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [646] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [647] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [648] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [649] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [650] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [651] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [652] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [653] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [654] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [655] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [656] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [657] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [658] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [659] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [660] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [661] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [662] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [663] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [664] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [665] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [666] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [667] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [668] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [669] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [670] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [671] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [672] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [673] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [674] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [675] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [676] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [677] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [678] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [679] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [680] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [681] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [682] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [683] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [684] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [685] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [686] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [687] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [688] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [689] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [690] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [691] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [692] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [693] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [694] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [695] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [696] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [697] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [698] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [699] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [700] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [701] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [702] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [703] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [704] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [705] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [706] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [707] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [708] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [709] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [710] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [711] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [712] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [713] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [714] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [715] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [716] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [717] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [718] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [719] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [720] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [721] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [722] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [723] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [724] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [725] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [726] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [727] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [728] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [729] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [730] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [731] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [732] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [733] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [734] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [735] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [736] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [737] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [738] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [739] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [740] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [741] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [742] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [743] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [744] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [745] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [746] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [747] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [748] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [749] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [750] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [751] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [752] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [753] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [754] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [755] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [756] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [757] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [758] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [759] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [760] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [761] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [762] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [763] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [764] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [765] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [766] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [767] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [768] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [769] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [770] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [771] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [772] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [773] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [774] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [775] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [776] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [777] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [778] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [779] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [780] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [781] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [782] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [783] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [784] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [785] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [786] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [787] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [788] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [789] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [790] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [791] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [792] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [793] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [794] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [795] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [796] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [797] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [798] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [799] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [800] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [801] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [802] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [803] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [804] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [805] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [806] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [807] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [808] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [809] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [810] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [811] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [812] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [813] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [814] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [815] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [816] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [817] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [818] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [819] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [820] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [821] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [822] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [823] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [824] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [825] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [826] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [827] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [828] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [829] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [830] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [831] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [832] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [833] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [834] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [835] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [836] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [837] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [838] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [839] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [840] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [841] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [842] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [843] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [844] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [845] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [846] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [847] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [848] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [849] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [850] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [851] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [852] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [853] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [854] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [855] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [856] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [857] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [858] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [859] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [860] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [861] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [862] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [863] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [864] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [865] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [866] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [867] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [868] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [869] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [870] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [871] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [872] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [873] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [874] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [875] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [876] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [877] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [878] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [879] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [880] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [881] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [882] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [883] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [884] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [885] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [886] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [887] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [888] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [889] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [890] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [891] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [892] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [893] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [894] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [895] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [896] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [897] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [898] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [899] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [900] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [901] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [902] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [903] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [904] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [905] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [906] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [907] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [908] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [909] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [910] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [911] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [912] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [913] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [914] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [915] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [916] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [917] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [918] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [919] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [920] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [921] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [922] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [923] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [924] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [925] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [926] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [927] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [928] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [929] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [930] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [931] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [932] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [933] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [934] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [935] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [936] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [937] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [938] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [939] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [940] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [941] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [942] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [943] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [944] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [945] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [946] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [947] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [948] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [949] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [950] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [951] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [952] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [953] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [954] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [955] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [956] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [957] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [958] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [959] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [960] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [961] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [962] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [963] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [964] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [965] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [966] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [967] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [968] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [969] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [970] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [971] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [972] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [973] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [974] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [975] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [976] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [977] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [978] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [979] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [980] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [981] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [982] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [983] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [984] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [985] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [986] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [987] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [988] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [989] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [990] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [991] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [992] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [993] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [994] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [995] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [996] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [997] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [998] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [999] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1000] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1001] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1002] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1003] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1004] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1005] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1006] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1007] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1008] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1009] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1010] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1011] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1012] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1013] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1014] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1015] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1016] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1017] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1018] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1019] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1020] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1021] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1022] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1023] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1024] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1025] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1026] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1027] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1028] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1029] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1030] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1031] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1032] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1033] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1034] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1035] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1036] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1037] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1038] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1039] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1040] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1041] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1042] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1043] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1044] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1045] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1046] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1047] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1048] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1049] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1050] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1051] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1052] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1053] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1054] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1055] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1056] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1057] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1058] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1059] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1060] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1061] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1062] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1063] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1064] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1065] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1066] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1067] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1068] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1069] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1070] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1071] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1072] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1073] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1074] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1075] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1076] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1077] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1078] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1079] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1080] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1081] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1082] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1083] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1084] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1085] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1086] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1087] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1088] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1089] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1090] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1091] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1092] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1093] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1094] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1095] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1096] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1097] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1098] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1099] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1100] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1101] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1102] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1103] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1104] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1108] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1109] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1110] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1111] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1112] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1113] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1114] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1115] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1118] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1119] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1120] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1121] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1122] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1123] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1124] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1125] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1126] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1127] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1128] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1129] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1131] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1132] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1133] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1134] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1137] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1138] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1140] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1143] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1148] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1149] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1150] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1151] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1152] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1154] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1155] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1157] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1158] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1159] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1160] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1161] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1162] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1164] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1165] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1166] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1167] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1168] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1169] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1170] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1171] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1172] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1173] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1174] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1176] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1177] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1178] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1179] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1181] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1182] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1183] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1184] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1185] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1186] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1187] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1188] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1189] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1190] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1193] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1195] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1198] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1200] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1201] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1202] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1203] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1204] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1205] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1206] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1208] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1209] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1210] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1211] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1212] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1213] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1214] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1216] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1219] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1220] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1221] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1222] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1223] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1224] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1225] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1226] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1228] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1229] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1230] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1231] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1236] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1237] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1238] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1239] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1241] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1242] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1243] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1244] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1245] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1246] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1247] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1248] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1249] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1252] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1253] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1258] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1260] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1261] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1262] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1263] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1264] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1265] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1266] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1267] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1268] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1270] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1272] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1273] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1274] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1275] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1276] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1277] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1278] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1280] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1281] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1282] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1283] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1286] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1288] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1289] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1290] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1292] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1293] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1294] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1295] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1296] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1297] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1298] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1303] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1304] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1305] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1306] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1307] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1308] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1309] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1310] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1312] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1313] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1314] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1315] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1316] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1317] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1318] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1319] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1320] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1321] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1322] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1323] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1324] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1325] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1326] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1327] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1328] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1329] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1330] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1331] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1332] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1333] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1334] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1335] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1336] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1337] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1338] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1339] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1340] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1342] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1343] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1344] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1345] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1346] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1347] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1348] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1349] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1350] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1351] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1352] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1353] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1354] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1355] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1356] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1357] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1358] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1359] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1360] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1361] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1363] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1364] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1365] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1366] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1367] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1368] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1369] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1370] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1371] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1372] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1373] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1374] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1375] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1376] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1377] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1380] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1381] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1382] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1383] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1384] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1385] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1386] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1387] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1388] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1389] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1390] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1391] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1392] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1393] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1394] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1395] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1396] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1397] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1398] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1399] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1400] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1401] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1402] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1405] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1406] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1409] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1410] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1411] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1412] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1413] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1414] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1415] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1416] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1417] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1418] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1419] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1421] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1422] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1423] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1424] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1425] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1426] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1427] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1428] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1429] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1430] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1432] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1435] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1436] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1437] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1438] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1439] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1440] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1441] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1442] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1443] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1444] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1445] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1446] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1447] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1448] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1449] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1450] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1451] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [1452] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1453] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1454] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1455] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1456] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1457] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1458] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1459] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1461] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1466] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1467] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1468] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1469] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1470] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1471] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1472] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [1473] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1474] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1475] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1476] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [1477] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1478] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1479] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [1480] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025.